Headquartered in Lisle, IL Fiscal year ends December NYSE: CTS ctscorp.com
CTS Corporation (NYSE: CTS) designs and manufactures sensors, actuators, and electronic components that 'Sense, Connect and Move.' The company serves four primary end markets: aerospace & defense, industrial, medical, and transportation. CTS manufactures products across North America, Europe, and Asia, providing engineered solutions including eBrake technology, foot controls, sensing applications, precision measurement devices, implantable sensing products, and temperature sensing solutions. The company's diversification strategy has shifted its revenue mix, with diversified end markets (industrial, aerospace & defense, and medical) now representing 60% of total sales. CTS has been actively pursuing acquisitions to accelerate diversification, most recently announcing the acquisition of Millar, a precision pressure sensing company serving medical, life sciences, and industrial applications with expertise in MEMS pressure, pH, and conductivity sensing technologies. Updated
Management raised full-year adjusted EPS guidance to $2.78 to $2.88 from $2.55 to $2.70, so the margin story is now baked into the outlook investors are paying for. Adjusted gross margin widened 330 basis points to 42.2%, helped by diversified end markets and the newly closed Millar deal.
Goldman Sachs models $765 billion in annual AI capital spending for 2026, climbing toward $1.6 trillion by 2031. That kind of multi-year buildout is the backdrop for three actively managed (or active-leaning)…
CTS Corporation (NYSE: CTS) designs and manufactures sensors, actuators, and electronic components that 'Sense, Connect and Move.' The company serves four primary end markets: aerospace & defense, industrial, medical, and transportation.
The Wall Street consensus 12-month price target for CTS is $73.67.
